T he federal government began using administrative data to publicly report hospital mortality rates after coronary artery bypass grafting (CABG) surgery in the 1980s. Shortly thereafter, large, clinically based registries (eg, The Society of Thoracic Surgeons' [STS] Adult Cardiac Surgery Database) emerged in part to address perceived concerns over inadequate risk adjustment inherent within administrative claims. Currently, nearly 100% of all US cardiac surgical programs voluntarily submit data to the STS. Although STS participants in turn receive quarterly benchmarking reports, some have argued that gains in surgical outcomes are largely unrelated to voluntary reporting programs. 1 Physician-led quality collaboratives have developed as a mechanism for using data (eg, STS for cardiac surgery) to improve the quality and safety of care. As an example, all 33 nonfederal cardiac surgical programs in Michigan participate voluntarily both in the STS and the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, the latter is funded in part by the largest statewide private healthcare payer. This collaborative supplements STS reporting with quarterly face-to-face meetings showcasing unblinded center-level data to discuss barriers and obstacles to driving local quality improvement. 2 Although a number of reports have evaluated the effectiveness of such a collaborative learning model, 3, 4 most have been limited by their lack of a contemporaneous control population.
To understand the role of participation in a physician-led quality improvement collaborative relative to a national physician reporting program, we evaluated reductions in postcardiac surgery pneumonia rates associated with a statewide pneumonia prevention initiative. Pneumonia, the most common healthcare-associated infection in this setting, occurs among 3% of patients and is associated with a 4-fold increased odds of mortality and 3-fold increased length of stay. 5 Specifically, we compared pneumonia rates between hospitals participating in a statewide collaborative initiative and hospitals that solely participated in a national physician reporting program. We secondarily assessed whether there were further reductions in pneumonia rates associated with receipt of additional feedback on recommended pneumonia practices among a subset of collaborative hospitals.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. This study was approved by the Institutional Review Boards at Duke University (Pro00056095), the University of Michigan (HUM00084088), and registered at URL: https://www.clinicaltrials.gov (Unique identifier: NCT02068716). No informed consent was required.
Site Selection
During the period of July 1, 2011, through June 30, 2017, 1198 hospitals participated in the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS, n=1198). All 33 Michigan nonfederal hospitals performing cardiac surgery voluntarily participated in both the STS and in a physician-led quality improvement collaborative.
Data Source and Collaborative Intervention
Hospitals participating in the STS submit data harvest files quarterly to the STS data warehouse and in turn receive standardized, blinded, comprehensive benchmarking reports for quality assurance and improvement. These reports provide each hospital with its observed performance relative to both a comparable group (based on case volume and presence of a surgical residency program) and national outcomes.
In addition to their participation in the STS, all 33 Michigan hospitals also participate in the Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative (MI-Collaborative). The MI-Collaborative quarterly face-toface meetings (attended by surgeons, database managers, and perfusion representatives from each hospital) include unblinded center results along with STS benchmarks and discussions about perceived barriers and facilitators for local quality improvement projects. The MI-Collaborative also shares quarterly electronic benchmarking reports, which are designed to supplement the existing STS reports, that graphically depict each hospital's performance against the other 32 hospitals along with an STS benchmark (when available).
WHAT IS KNOWN
• Nearly 100% of all hospitals performing adult cardiac surgery in the United States participate in the Society of Thoracic Surgeons Adult Cardiac Surgery Database, which is often used to benchmark quality in cardiac surgery.
• It is unknown whether participation in a physician-led collaborative in Michigan that leverages collaborative learning and quality benchmarking is independently associated with improved outcomes relative to quality benchmarking alone.
WHAT THE STUDY ADDS
• We found that a collaborative learning intervention focusing on postoperative pneumonia after cardiac surgery yielded significant reductions in pneumonia relative to quality benchmarking alone.
• Risk-adjusted pneumonia rates declined by 1 At the MI-Collaborative November 2012 meeting, the attendees agreed to undertake a statewide pneumonia prevention intervention to address observed variation in post-cardiac surgery infection rates. 6 During this meeting, attendees were presented with data about the variability and impact of healthcare-associated infections after CABG surgery across the MI-Collaborative hospitals. The MI-Collaborative embarked on a multifaceted initiative including benchmarking site visits to high-and low-performing centers, face-toface meetings, and educational webinars.
Project materials are described in detail in the Methods in the Data Supplement. As previously described, the MI-Collaborative developed, endorsed, and distributed to all its hospitals a set of pneumonia prevention practice recommendations ( Table I in the Data Supplement), which were based on benchmarking site visits and structured literature review (unpublished data). Providers at each MI-Collaborative hospital attended each quarterly meeting and webinar materials were distributed to each surgical practice.
In addition, between Q1/2016 through Q4/2016, 18 of the 33 centers ("MI-CollaborativePlus") agreed to voluntarily receive (in addition to their ongoing STS and collaborative quarterly reports) monthly data feedback detailing CABG-specific pneumonia prevention practices. None of the interventions were mandated. While encouraged to be multidisciplinary, the cardiac surgeon lead at each of the 18 hospitals independently chose which specialties and disciplines (eg, respiratory therapy, nurse practitioner, anesthesiologist) to include in its quality improvement team. The remaining 15 hospitals ("MI-CollaborativeOnly") solely participated in ongoing collaborative and STS activities. Quarterly collaborative meetings were used to examine and evaluate the effectiveness of our intervention in reducing pneumonia rates.
Primary Outcomes
The primary outcome was postoperative pneumonia. All STS participating centers adhere to a common STS pneumonia definition, which is based on laboratory findings (eg, positive sputum culture results from transtracheal fluid and bronchial washings) and/or radiological evidence (eg, chest roentgenogram diagnostic of pulmonary infiltrates). 7 Fever and white blood cell count are considered as evidence of pneumonia.
Statistical Analysis
We identified 1 721 345 patients undergoing cardiac surgery between July 1, 2011, and June 30, 2017, at 1198 hospitals participating in the STS. After excluding patients receiving procedures other than isolated CABG surgery or those presenting with active or treated endocarditis, equaled 911 754 patients (n=196 954 preintervention, 714 800 intervention), representing 1197 participating hospitals, were available for subsequent analysis (Figure 1 ).
Descriptive statistics were compared using χ 2 analysis for binary or nominal categorical variables and the Wilcoxon test or Kruskal-Wallis test for continuous or ordinal categorical variables. Our analysis captured the effect of the intervention using 2 linear splines to account for time from the start of the study (July 2011) as well as start of the intervention (November 2012). A multivariable logistic regression model using a unique random intercept for each hospital was used to model the risk of pneumonia. Model fit was analyzed using C-statistic, as well as looking at the calibration between observed and expected. Additional sensitivity analyses examined the effect of each hospital in the MI-Collaborative to determine if hospitals that had the highest baseline risk for pneumonia exhibited the strongest decline during the study period.
Furthermore, we calculated observed/expected ratios for stratum-specific results with the goal to assess the rates of change over time. These were presented for both pre-intervention and intervention time periods for MI-Collaborative (and separately for the MI-CollaborativeOnly and MI-CollaborativePlus groups), STS hospitals not participating in the MI-Collaborative (STS-nonMI), and all STS hospitals. Where the observed/expected is the ratio of a specific stratum's (ie, pre-intervention period for MI-CollaborativePlus) mean number of observed post-operative pneumonia events relative to the mean number of pneumonia events expected by the model we generated, while accounting for patient mix and hospital effects. Risk-adjusted rates were calculated by multiplying the O/E ratio by the overall unadjusted rate of pneumonia during our study period. P values comparing O/E ratios between groups and time periods were obtained using a Wald test statistic for testing the null hypothesis that the 2 groups had equal O/E ratios.
Statistical analyses were performed using SAS version 9.4 (SAS Institute, Inc, Cary, NC) and R version 3.4.2 (R Foundation for Statistical Computing, Vienna, Austria). The 2-tailed tests were considered significant at P <0.05. Table 1 .
RESULTS
Overall, in the preintervention period, nearly 60% of patients were urgent, mean age was 64.9 years, 26.1% were female, average white blood cell count before surgery was 8.2, 14.3% had peripheral arterial disease, 44.5% had diabetes mellitus, 2.9% had a recent history of pneumonia, 22.8% were current cigarette users, 10.5% had moderate to severe chronic lung disease, and 10.4% had ejection fractions <35% (Table 1, Table  II in the Data Supplement). Relatively small absolute differences existed across groups and over time with some exceptions: MI-Collaborative patients presented with more cerebrovascular disease (in the intervention period), more recent history of pneumonia (in both time periods), more mild and severe chronic lung disease (both time periods), all P<0.001.
In aggregate, >80% of procedures used cardiopulmonary bypass in the pre-intervention period ( Table 2) . The mean bypass duration was 95.7 minutes, whereas cross-clamp duration was 58.3 minutes. Almost all patients received appropriate selection, timing, and discontinuation of antibiotics. Nearly 35% of patients received blood products intraoperatively (average of 1.8 U transfused) and 38.9% were transfused postoperatively (average of 2.5 U transfused). More than 10% of patients were intubated >24 hours, 13.7% developed major morbidity/mortality and 2.4% died within 30 days. Relatively small absolute differences existed across groups and over time, with some exceptions: MI-Collaborative patients were more likely to receive surgery using cardiopulmonary bypass (both time periods), had longer bypass (both time periods), and cross-clamp durations (both time periods), although they were less likely to receive blood (pre-intervention) products intra-or postoperatively. Blood product utilization diminished over time for both groups, as did rates of prolonged intubation and major morbidity. Operative mortality did not appreciably change over time. In addition, cardiopulmonary bypass and cross-clamp durations were longer for patients operated at MI-CollaborativePlus hospitals relative to other groups (Table III in There were decreases over time in observed pneumonia rates in each of the patient subgroups (Table 3,  Table IV in the Data Supplement). Pneumonia rates were either equivalent or lower in Michigan (MI-Collaborative or by MI-CollaborativePlus and CollaborativeOnly) relative to STS-nonMI.
DISCUSSION
In this large, statewide quality improvement study using clinical registry data, we found that hospitals participating in a physician-led quality collaborative had a significant, greater decline in adjusted pneumonia rates relative to the rest of the country. Declines in adjusted pneumonia rates were greatest among the MI-Collab-orative hospitals with enhanced feedback about pneumonia prevention practices (10% versus 2% reduction). We estimate that broader adoption of collaborative learning would result in 2017 fewer pneumonia cases across the United States over the course of the intervention period. To our knowledge, these findings are the first to quantitatively assess the effectiveness of participating in a physician-led quality improvement collaborative relative to a national reporting program.
Approximately 1 out of every 25 hospitalized patients develops an healthcare-associated infection. 8 Cardiac surgical patients are more likely to develop major morbidity and mortality at high (17.9%) versus low (8.6%) healthcare-associated infection rate hospitals (P<0.001). 9 Rates of healthcare-associated infections after cardiac surgery, which are predominantly accounted for by pneumonia, vary considerably across hospitals. 6, 9 Perhaps surprisingly, only 2% of the overall variability in pneumonia rates is accounted for by differences in patient-level risk factors, 10 suggesting that pneumonia rates are likely driven by factors other than patient comorbidities and the duration of the operation.
The STS is the largest clinical database for cardiac surgery, covering nearly 100% of all US-based hospitals. Data from the STS are used for research, public reporting, and quality improvement. We found that hospitals participating in the STS had reductions in pneumonia. We hypothesize that the underlying national reduction in healthcare-associated infections, including pneumonia, may be attributed in part to the general increased awareness of healthcare-associated infections, in part because of the efforts of the Agency for Healthcare Research and Quality. 11 During the time period of our study, hospitals participating in the STS received quarterly feedback reports documenting each center's performance over time relative to a comparable hospital and the national average. These detailed reports contain risk-adjusted outcomes and are designed to be comprehensive, spanning over 200 pages. Nonetheless, evidence suggests that by itself, feedback reporting does not result in largescale reductions in morbidity or mortality. 1 Prior reports have documented targeted quality improvement associated with physician-led quality improvement collaboratives. One of the earliest efforts was conducted by the Northern New England Cardiovascular Disease Study Group. 12 Use of validated, clinically derived data feedback to frontline care providers, along with quality improvement training, was associated with a 24% reduction in in-hospital mortality after CABG surgery, P=0.001. Subgroup analyses documented robust findings across important patient subgroups. This model has been replicated both within 3, 13 and outside of cardiac surgery. 14, 15 Indeed, the largest commercial insurer in Michigan (Blue Cross and Blue Shield of Michigan/Blue Care Network) financially supports 17 of these collaboratives, including those focused on cardiothoracic surgery, interventional cardiology, orthopedic surgery, bariatric surgery, and anticoagulation. 16 Prior reports have documented the improvements in quality and expenditure associated with this partnership. 15 The MI-Collaborative is the only participating value collaborative that is organized through a statewide professional society.
Current evaluations of physician-led quality improvement initiatives have predominantly focused on local, state, and regional experiences. Paone et al 4 In this present study, participation in a physicianled quality improvement collaborative was associated with greater reductions in postoperative pneumonia relative to national norms. Several reasons might help explain these findings. First, the MI-Collaborative identified discrete pneumonia prevention measures that clinical teams could focus on to improve their performance. Although the Michigan intervention hospitals received monthly feedback reports, all Michigan hospitals participated in our quarterly MI-Collaborative conferences. These conferences routinely were preceded with a 1-hour infection prevention workgroup meeting that was open to all MI-Collaborative conference attendees. Second, the MI-Collaborative is one of the few surgical collaboratives to unblind center data at their quarterly collaborative conferences. On the basis of trust and mutual respect, unblinding has facilitated sharing of best practices as well as fostered peer-to-peer accountability of each center's results. Third, several resources were made available to Michigan hospitals, including education materials (eg, webinars, summary of published literature) focusing on pneumonia prevention practices to support local adoption of best practices. Fourth, although other clinical teams beyond Michigan have been exposed to the same evidence-based literature detailing pneumonia-preventive practices, we are unaware of any systematic pneumonia prevention initiatives underway outside of our collaborative during this time period.
A number of other regional quality improvement collaboratives exist, with many participating in a voluntary network-The IMPROVE Network. 18 The IMPROVE Network comprised 7 physician-led quality collaboratives that collectively represent nearly 10% of all US-based cardiac surgery hospitals. Hospitals in each collaborative contribute surgical data to a robust data coordinating center. Adoption of the pneumonia prevention practices across hospitals participating in this voluntary network would serve to externally validate our current findings. We recognize some limitations to the present study. First, we cannot rule out the impact of selection bias (Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative centers voluntarily chose to participate in the MI-CollaborativePlus relative to MICollaborativeOnly), which may help explain the signifi- cant reduction in pneumonia rates relative to national norms achieved by the MI-CollaborativeOnly hospitals ( Figure II in the Data Supplement). Second, we cannot rule out systematic differences in reporting pneumonia rates across the 3 groups. Nonetheless, all hospitals participating in this study are subjects to the STS' random external data auditing process. 19 Each MI-Collaborative center additionally undergoes routine data quality audits. Third, we cannot rule out other factors that may have contributed to the observed findings, including other quality improvement initiatives undertaken by the hospitals in Michigan. Our findings appear to be robust, as evidenced through subgroup analyses. Finally, our findings are subject to unmeasured confounding given the absence of randomization in our study design. We addressed this concern through risk adjustment, accounting for patient and center-level effects.
Postoperative pneumonia rates have significantly declined over time for hospitals participating in a national cardiac surgery reporting program. Nonetheless, the rates of decline were significantly accelerated for hospitals participating in a physician-led statewide quality improvement study. Beyond the need to evaluate broader dissemination of these pneumonia prevention practices, our findings provide further evidence supporting the benefit of physician-led collaboratives.
